ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0080 • ACR Convergence 2025

    The Role of DICAM in Modulating Macrophage Differentiation and Inflammatory Responses via αvβ3 Integrin Signaling in Rheumatoid Arthritis

    Hanna Lee1, Youn-Kwan Jung2, Sang-il Lee3, Yun-Hong Cheon4 and Hyunjin Lim4, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Hospital, Changwon, Changwon-si, Kyongsang-namdo, Republic of Korea, 2Institute of Medical Science, Gyeongsang National University, Jinju, Jinju, Kyongsang-namdo, Republic of Korea, 3Department of Internal Medicine and Institute of Medical Science, College of Medicine, Gyeongsang National University and Hospital, Jinju, Republic of Korea, 4Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Jinju, Kyongsang-namdo, Republic of Korea

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent joint inflammation, cartilage destruction, and bone erosion. Among the various immune cells involved…
  • Abstract Number: 0140 • ACR Convergence 2025

    Outcome Of Patients With Non-Criteria Manifestations Of Primary Antiphospholipid Syndrome Treated With Immunosuppressants -A Single Centre Study

    Sindhuja Rajendran1, ashish mathew2, sukesh chandran nair3, john mathew2 and ruchika goel2, 1Christian Medical College ,Vellore, Madurai, Tamil Nadu, India, 2Christian Medical college , Vellore , India, Vellore, Tamil Nadu, India, 3Christian,Medical College ,Vellore ,India, Vellore, Tamil Nadu, India

    Background/Purpose: Non-criteria manifestations occur in 24% in Primary antiphospholipid syndrome (PAPS) . The efficacy of immunosuppressants in patients with above condition is not certain due…
  • Abstract Number: 0205 • ACR Convergence 2025

    Implementation of the Varicella Zoster virus vaccine and its Real-World effectiveness

    Laura Mas Sanchez1, ELENA GRAU GARCIA2, Carlos Valera Ribera3, Pablo Muñoz-Martínez4, Daniel Ramos Castro5, Alba Maria Torrat Noves6, Belen Villanueva Manes7, Iago Alcántara Álvarez8, Miguel Simeo Vinaixa9, Andres Perez Hurtado10 and José Andrés Román Ivorra11, 1Hospital Universitari i Politecnic La Fe, València, Spain, 2HUP La Fe, Valencia, Comunidad Valenciana, Spain, 3Hospital Universitario Doctor Peset, València, Spain, 4Hospital Universitario y Politécnico La Fe, Sagunto, Spain, 5Hospital Universitari i Politecnic La Fe, Valencia, Spain, 6Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain, 7Hospital La Fe, València, Spain, 8Hospital Universitari i Politénic La Fe, València, Spain, 9Rheumatology Department. HUP La Fe, Valencia, Spain, 10Hospital Universitario y Politècnico La Fe, València, Comunidad Valenciana, Spain, 11Hospital Universitari i Politècnic La Fe, Valencia, Spain

    Background/Purpose: In 2023, Spain approved the inactivated varicella zoster virus (VZV) vaccine in individuals over 50 years of age with immunosuppressive conditions, including rheumatology patients…
  • Abstract Number: 0186 • ACR Convergence 2025

    Validation of Asynchronous Telehealth Visit for Adults and Children with Inflammatory Arthritis and Feasibility of Applying Thermal Imaging during Visits

    Jenna Thomason1, Rajdeep Pooni2, Erin Sullivan3, Adriel Liau3, Sadie Van den Bogaerde1, Iris Hamilton3, Sriya Paluvayi3, Megan Tran4, Janeth Robles-Navarro4, Ian Muse5, Audrey Luey4, Ava Klein3, Debosmita Biswas4, Savannah Partridge4, Tzielan Lee6, Alison Bays1, Grant Hughes7, Elizabeth Ferucci8 and Yongdong (Dan) Zhao9, 1University of Washington, Seattle, WA, 2Stanford University, Berkeley, CA, 3Seattle Children's Hospital, Seattle, 4University of Washington, Seattle, 5University of Washington, Department of Pediatrics, Seattle Children's Hospital, Seattle, 6Stanford University School of Medicine, Palo Alto, CA, 7University of Washington, Lynnwood, WA, 8Alaska Native Tribal Health Consortium, Anchorage, AK, 9Seattle Children’s Research Institute, Redmond, WA

    Background/Purpose: Use of telemedicine has increased substantially. Our overall goal was to assess the utility of a standardized video joint exam and infrared thermal imaging…
  • Abstract Number: 0150 • ACR Convergence 2025

    Mortality in Anca-associated Vasculitis

    Fabricio Benavides Villanueva1, Vanesa Calvo-Río2, Diana Prieto-Peña3, Monica Renuncio-García4, Adrian Martin-Gutierrez5, Amparo Sanchez-Lopez6, Claudia Poo-fernandez7, Clara Escagedo-Cagigas8, maria Rodríguez-Vidriales8 and Ricardo Blanco2, 1Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Immunopathology Group,Santander, Spain, Santander, Spain, 2Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 3Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Spain, 4Division of Immunology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Cantabria, Spain, 5Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Renedo de Piélagos, Spain, 6Division of Dermatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Cantabria, Spain, 7Division of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Cantabria, Spain, 8Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Cantabria, Spain

    Background/Purpose: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), include Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Eosinophilic Granulomatosis with Polyangiitis (EGPA). Mortality rates are scare,…
  • Abstract Number: 0194 • ACR Convergence 2025

    Evaluation of a Home-based Therapeutics Service: Feasibility, Patient and Caregiver Experience, and Cost

    Xiaohui Xin, Andrea Low, Sow Ling Yee, Miao Miao Liu, Christina Tan, Daphne Ng and Siaw Ing Yeo, Singapore General Hospital, Singapore, Singapore

    Background/Purpose: The home-based therapeutics service (HTS) by a community nurse is part of an ongoing larger initiative—Community Therapeutics Programme (CTP)—spearheaded by the Rheumatology and Immunology…
  • Abstract Number: 0215 • ACR Convergence 2025

    Impact of Global Review on Comorbidity Management in Inflammatory Arthritis Patients

    Alexandra Kobza1, Camille Bourgeois2, Olivier Fogel3, Maxime Dougados4 and Anna Molto5, 1University of Calgary, North Vancouver, BC, Canada, 2Hospital general universitario Gregorio Marañon, Madrid, Madrid, Spain, 3AP-HP, Paris, France, 4Department of Medicine, Hopital Cochin, Universite de Paris, Paris, France, 5Assistance Publique Hôpitauxde Paris, Paris, France

    Background/Purpose: Patients with inflammatory arthritis (IA), including rheumatoid arthritis (RA) and spondyloarthritis (SpA), face elevated risk for comorbidities that complicate disease management. Although rheumatology societies…
  • Abstract Number: 0202 • ACR Convergence 2025

    Saudi Society for Rheumatology Consensus Recommendation on Vaccination Strategies in Adults Saudi with Autoimmune Rheumatic Disorders

    Fahidah Alenzi1, Hanan Alrayes2, Khawla K Alghanim3, FEHAID ALANAZI4, Mohammed Attar5, Mansour Alazmi6, Suzan Attar7, Nisreen Alsherbeeni8, Azzam Alotaibi9 and Fayssal M Farahat10, 1Associate Professor and Consultant Rheumatology, Department of Internal Medicine, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, 2Riyadh Military - Prince Soltan Military Medical City ( PSMMC ) - Olaya, Riyadh, Saudi Arabia, 3Consultant Rheumatologist and lupus specialist, Department of Internal Medicine, Rheumatology Unit, King Fahad Military Medical Complex, Dhahran, Saudi Arabia, Dhahran, Saudi Arabia, 4King Khaled university Hospital, Riyadh, Saudi Arabia, 5Al hada armed forces hospital, Taif, Saudi Arabia, 6Internal Medicine and Rheumatology Consultant , Prince Mohammed Medical City, Aljouf , Saudi Arabia, Sakaka- Aljouf, Saudi Arabia, 7King Abdulaziz University, Saudi Arabia, Jeddah, Saudi Arabia, 8Consultant Internal Medicine & Infectious Disease, Infectious Disease Division Department of Medicine at Prince Sultan Military Medical City, Riyadh, Saudi Arabia, 9Consultant Internal Medicine, Allergy, and Immunology, Division of Allergy and Immunology, Department of Medicine at Prince Sultan Military Medical City, Riyadh, Saudi Arabia, 10Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, P.O. Box 22490, Riyadh 11426, Saudi Arabia; College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, P.O. Box 3660, Riyadh 11481, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, P.O. Box 3660, Riyadh 11481, Saudi Arabia, Riyadh, Saudi Arabia

    Background/Purpose: Patients with autoimmune inflammatory rheumatic diseases (AIIRD) are at increased risk of infections due to both immune system dysfunction and the use of immunosuppressive…
  • Abstract Number: 0206 • ACR Convergence 2025

    Prospective Controlled Study of Humoral Response to Recombinant Zoster Vaccine in Cyclophosphamide-Treated Autoimmune Rheumatic Disease Patients: No Additional Impairment Compared to Other Immunosuppressive Therapies

    Nadia Emi Aikawa1, Julia Medeiros2, Sandra G Pasoto3, Ana C Medeiros-Ribeiro3, Luciana Parente Costa Seguro4, Ana Paula Luppino-Assad5, Emily Figueiredo Neves Yuki6, Lissiane Guedes7, Clovis Artur Silva8 and Eloisa Bonfa4, 1Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 4Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, 5Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SAO PAULO, Brazil, 6Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil, 7Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, 8University of São Paulo, São Paulo, São Paulo, Brazil

    Background/Purpose: Recombinant zoster vaccine (RZV), represents a major advancement in the prevention of herpes zoster in autoimmune rheumatic diseases (ARD) patients. However, RVZ efficacy depends…
  • Abstract Number: 0163 • ACR Convergence 2025

    Trends in hospitalization and outcomes among patients admitted with Adult-onset Still’s disease in the United States: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (2016-2022)

    Mohammed Akram1, Muhammad Sohaib Asghar2, Woo Joo Lee2, Basmah Fayaz Yousuf3, Carmen Tormo Carillo4 and Savier Aleman Rama4, 1HCA Aventura, Aventura, FL, 2AdventHealth Sebring, Sebring, FL, 3SUNY Downstate Health Sciences University, New York, NY, 4HCA Florida Aventura Hospital, Aventura, FL

    Background/Purpose: Adult-onset Still's Disease is a rare systemic autoinflammatory disorder characterized by spiking fever, arthralgia/arthritis, skin rash, and elevated inflammatory markers (ferritin). Estimated incidence ranges…
  • Abstract Number: 0166 • ACR Convergence 2025

    Effect of Air Pollution on Prevalence and Disease Activity of Rheumatoid Arthritis in the German Middle-aged Population from the NAKO Baseline Examination

    Tim Filla1, Gamal Chehab1, Jutta Richter2, Jörg Distler3 and Oliver Sander1, 1Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University., Düsseldorf, Germany, 2Clinic for Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, Düsseldorf, Germany, 3University Hospital Duesseldorf and HHU, Duesseldorf, Germany

    Background/Purpose: Environmental influences affect the human body throughout life, from conception to old age. The influence of air pollution and fine dust particles on systemic…
  • Abstract Number: 0158 • ACR Convergence 2025

    Association between newer COVID-19 vaccines and COVID-19 related hospitalizations among people with autoimmune rheumatic diseases in the U.S. National COVID Cohort Collaborative (N3C)

    Lesley Jackson1, jerrod anzalone2, Rahima Begum3, Fazlur Rahman1, Namrata Singh4, Londyn Robinson5, Kaleb Michaud2, Kenneth Saag6, Jasvinder Singh7, Rena Patel1 and Maria I. ("Maio") Danila8, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Nebraska Medical Center, Omaha, NE, 3University of Alabama at Birmingham, Birmingham, 4University of Washington, Bellevue, WA, 5University of Washington, Seattle, WA, 6The University of Alabama at Birmingham, Birmingham, AL, 7Baylor College of Medicine, Houston, TX, 8University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: People with autoimmune rheumatic diseases (AIRD) are at higher risk for serious complications and poor outcomes from COVID-19 infection. Data is lacking on outcomes…
  • Abstract Number: 0155 • ACR Convergence 2025

    Effect Modification of Cigarette Smoking on the Relationship between Post Traumatic Stress Disorder and Rheumatoid Arthritis Risk

    Kelsey Coziahr1, Harlan Sayles1, Tate Johnson1, Joshua Baker2, Punyasha Roul3, Grant Cannon4, Gary Kunkel5, Bryant England1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3UNMC, Omaha, NE, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Salt Lake City VA, Salt Lake City, UT

    Background/Purpose: Post-traumatic stress disorder (PTSD) is associated with increased systemic inflammation that may increase the risk of developing autoimmune disorders such as rheumatoid arthritis (RA).…
  • Abstract Number: 0087 • ACR Convergence 2025

    Integrative Metabolomic and Inflammatory Profiling in Rheumatoid Arthritis: Disease activity, therapeutic modulation, and underlying hepatic mechanisms

    Laura muñoz-Barrera1, Carlos Pérez Sánchez2, Rafaela Ortega-Castro3, Sagrario Corrales1, Tomás Cerdó1, Ismael Sanchez-Pareja1, Pilar Font4, Jerusalen Calvo Gutierrez5, M Carmen Abalos-Aguilera6, Desiree Ruiz-Vilchez7, Pedro Seguí-Azpilcueta8, Christian Merlo-Ruiz6, Jose Javier Pérez Venegas9, DOLORES RUIZ MONTESINOS10, Carmen Maria Romero Barco11, Antonio Fernández-Nebro12, Natalia Mena Vázquez13, FRANCISCO JAVIER GODOY NAVARRETE14, ALBA MARIA CABEZAS LUCENA15, MARIA ANGELES AGUIRRE ZAMORANO1, Nuria Barbarroja16, Alejandro Escudero17 and Chary López pedrera18, 1Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Córdoba, Spain, 2Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain/ CobiomicBioscience S.l, Cordoba, Spain, Cordoba, Spain, 3Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Andalucia, Spain, 4Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, SpainBiomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Spain, 5Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Sevilla, Spain, 6Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Córdoba, Spain, 7Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, 8Radiology Service, Reina Sofia Hospital/Maimonides Institute for Research in Biomedicine of Cordoba/University of Cordoba, Spain, Córdoba, United Kingdom, 9Virgen Macarena University Hospital, Sevilla, Spain, Sevilla, Spain, 10Virgen Macarena University Hospital, Sevilla, Spain, Cordoba, 11Virgen de la Victoria Hospital Malaga, Spain, Malaga, Spain, 12Hospital Regional Universitario de Malaga, Malaga, Spain, Malaga, Spain, 13Hospital Regional Universitario de Malaga, Malaga, Spain, Málaga, Spain, 14Jaen University Hospital, Spain, Jaen, Spain, 15Jaen University Hospital, Spain, Jaen, 16Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain/CobiomicBioscience S.l, Cordoba, Spain, Cordoba, Spain, 17Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Córdoba, Andalucia, Spain, 18Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Spain

    Background/Purpose: Lipid metabolism plays a key role in immune cell plasticity, influencing activation, differentiation and function. Inflammation alters this metabolism, contributing to disease progression. Extensive…
  • Abstract Number: 0084 • ACR Convergence 2025

    Regulation of the same chemokine gene transcription by different histone lysine methyltransferases, MLL1 and MLL3, in rheumatoid arthritis synovial fibroblasts

    Keita Okamoto1, Yasuto Araki2, Yoshimi Aizaki2, Hiroshi Kajiyama3, Kazuhiro Yokota2, Yu Funakubo2, Yuho Kadono4, Yuji Akiyama5 and Toshihide Mimura6, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Moroyama-chou, Iruma-gun, Saitama, Japan, 2Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 3Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Saitama, Japan, 4Department of Orthopaedic Surgery, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama, Japan, 5Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama, Japan, 6Saitama Seikeikai Hospital, Higashimatsuyama, Saitama, Japan

    Background/Purpose: Rheumatoid arthritis synovial fibroblasts (RASFs) produce various matrix metalloproteinases (MMPs), cytokines, and chemokines. Histone lysine methylation has been shown to play an important role…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology